Hello OHDSI community,
Next week we will be running a study-a-thon here in sunny Barcelona. We hope to answer the following three questions:
- What are the (medical) treatment/s given to patients with newly diagnosed RA in different healthcare systems in actual practice ini Europe and globally? [Drug Utilisation Study]
- What are the risk/s (including infection, cytopaenia, cancer, and cardiovascular disease) associated with different synthetic DMARDs for the treatment of RA? [Population Level Estimation study]
- Can we predict such risk/s (identified above) and generate algorithms for the identification of patients who should probably avoid specific treatment/s? [Patient Level Prediction study]
Even if you can’t join to enjoy the city with us, you can still contribute to the science! If you would be interested in contributing to any of these studies please comment below.